MedTrace Logo

Novel Pharmacotherapy for Dual Dependence

NCT00448825 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2013-03-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of Topiramate and Cognitive Behavioral Therapy for the treatment of alcohol and cocaine dependence.

Conditions

  • Alcohol Dependence
  • Cocaine Dependence

Interventions

DRUG

Topiramate + Cognitive Behavioral Therapy

Topiramate up to 300 mg per day

DRUG

Placebo + Cognitive Behavioral Therapy

Placebo twice a day

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Bankole Johnson

    lead OTHER

Principal Investigators

  • Bankole Johnson, DSc, MD, PhD · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00448825 on ClinicalTrials.gov